Cargando…
Acute Medication Use in Patients With Migraine Treated With Monoclonal Antibodies Acting on the CGRP Pathway: Results From a Multicenter Study and Proposal of a New Index
INTRODUCTION: Assessing the impact of migraine preventive treatments on acute medication consumption is important in clinical evaluation. The number of acute medication intakes per each monthly migraine day (MMD) could provide insights on migraine burden and represent a new proxy of treatment effect...
Autores principales: | Sette, Lucia, Caponnetto, Valeria, Ornello, Raffaele, Nežádal, Tomáš, Čtrnáctá, Dana, Šípková, Jitka, Matoušová, Zuzana, Sacco, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918478/ https://www.ncbi.nlm.nih.gov/pubmed/35295829 http://dx.doi.org/10.3389/fneur.2022.846717 |
Ejemplares similares
-
Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial
por: Ornello, Raffaele, et al.
Publicado: (2022) -
Patterns of Migraine in Postmenopausal Women: A Systematic Review
por: Ornello, Raffaele, et al.
Publicado: (2021) -
Acute and Preventive Management of Migraine during Menstruation and Menopause
por: Ornello, Raffaele, et al.
Publicado: (2021) -
Menstrual Headache in Women with Chronic Migraine Treated with Erenumab: An Observational Case Series
por: Ornello, Raffaele, et al.
Publicado: (2021) -
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
por: Lambru, Giorgio, et al.
Publicado: (2023)